文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

老年脓毒性休克患者重症监护后衰弱:一项多中心随机对照试验的事后分析

Postintensive Care Frailty of Older Patients With Septic Shock: A Post Hoc Analysis of a Multicenter Randomized Controlled Trial.
PubMed 文献 · Crit Care Med · 2026-08-12
一句话结论脓毒症前基线衰弱、SOFA评分和糖皮质激素使用独立预测老年脓毒性休克存活者90天重症监护后严重衰弱。

该研究为日本多中心RCT事后分析,纳入65岁及以上脓毒性休克患者513例,339例存活至90天。采用CFS评分将90天衰弱分为无至轻度(≤4)、中度(5-6)、重度(≥7),分别占30.4%、33.6%、36.0%。序贯logistic回归显示,脓毒症前CFS每增1分(aOR 2.03)、SOFA每增1分(aOR 1.16)及使用糖皮质激素(aOR 1.72)与衰弱独立相关。亚组分析提示,基线衰弱(CFS≥5)患者中糖皮质激素与衰弱恶化相关,组织低灌注(乳酸≥2 mmol/L)患者中SOFA评分与衰弱相关。

要点

  • 组织低灌注(乳酸≥2 mmol/L)患者中,SOFA评分与衰弱加重相关,提示该亚组需关注器官功能对远期功能状态的影响。
  • 90天存活者中36.0%为重度衰弱(CFS≥7),仅30.4%为无至轻度衰弱,提示多数存活者存在显著功能损害。

适用人群与场景

  • 纳入:65岁及以上脓毒性休克成人患者,数据来自日本ICU开展的多中心随机对照试验(研究最佳血压目标)。
  • 分析人群:513例 eligible 患者中存活至90天的339例。
  • 排除人群:原文未提及具体排除标准。

诊断标准与关键阈值

  • 衰弱分类依据90天时临床衰弱量表(CFS)评分:无至轻度为CFS≤4,中度为CFS 5-6,重度为CFS≥7。
  • 基线衰弱定义为脓毒症前CFS≥5(用于亚组分析)。
  • 组织低灌注定义为乳酸≥2 mmol/L(用于亚组分析)。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:多中心随机对照试验的事后分析,日本ICU开展,样本量513例 eligible,339例存活至90天。
  • 人群:65岁及以上脓毒性休克成人;干预与对照:原文未提及(事后分析未设特定干预对比)。
  • 主要终点结果:90天衰弱分布为无至轻度103例(30.4%)、中度114例(33.6%)、重度122例(36.0%)。
  • 亚组:基线衰弱(CFS≥5)患者中糖皮质激素与衰弱恶化相关;组织低灌注(乳酸≥2 mmol/L)患者中SOFA评分与衰弱相关。
  • 关键次要终点与不良事件:原文未提及。

证据类型、等级与局限

  • 证据类型:随机对照试验的事后分析(post hoc analysis)。
  • 证据等级或推荐强度:原文未提及。
  • 局限:事后分析设计;原文未提及其他局限(如单中心/多中心、回顾性、开放标签、样本小等)。

对床旁实践的改变

  • 对65岁及以上脓毒性休克存活者,应关注脓毒症前CFS评分,基线CFS≥5者90天衰弱加重风险更高(aOR 2.03/分)。
  • SOFA评分越高,90天衰弱加重风险越高(aOR 1.16/分),器官功能障碍严重程度可用于远期功能预后分层。
  • 糖皮质激素使用与90天衰弱加重独立相关(aOR 1.72),尤其基线CFS≥5患者;原文未提供剂量或疗程,不能据此改变用药方案。
  • 对乳酸≥2 mmol/L的组织低灌注患者,SOFA评分与衰弱加重相关,出院后功能随访可能需加强。
  • 该事后分析不能证明因果关系,糖皮质激素与衰弱的关联需前瞻性验证,不应据此停用有明确适应证的糖皮质激素。

指南或共识出处

  • 原文未提及(来源类型为Crit Care Med发表的随机对照试验事后分析,原文未给出指南或共识名称)。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVES: Postintensive care frailty impairs quality of life in survivors of severe illness. While anabolic hormone deficiency and prolonged inflammation are considered key physiologic mechanisms, specific features associated with frailty progression remain unclear. This study aimed to elucidate clinical characteristics associated with frailty deterioration following recovery from septic shock in older adults.

DESIGN: Post hoc analysis of a randomized controlled trial.

SETTING: ICUs in Japan.

PATIENTS: Adults of 65 years or older with septic shock.

MEASUREMENTS AND MAIN RESULTS: Data were analyzed from a randomized controlled trial investigating optimal blood pressure targets in patients of 65 years or older with septic shock. Frailty at 90 days after intensive care was classified as no-to-mild, moderate, and severe based on the Clinical Frailty Scale (CFS) scores of less than or equal to 4, 5-6, and greater than or equal to 7, respectively. Baseline characteristics, treatments, and outcomes were compared across these frailty categories. Factors associated with postintensive care frailty were identified using ordinal logistic regression fitted with a generalized estimating equation model. Among 513 eligible patients, 339 patients survived to 90 days; 103 patients (30.4%) had no-to-mild frailty, 114 patients (33.6%) had moderate frailty, and 122 patients (36.0%) had severe frailty, respectively. Higher presepsis CFS scores (adjusted odds ratio [aOR], 2.03 [1.72-2.40] per 1-point increase; p < 0.001), higher sequential organ failure assessment (SOFA) scores (aOR, 1.16 [1.06-1.26] per 1-point increase; p < 0.001), and corticosteroid use (aOR, 1.72 [1.14-2.61]; p < 0.001) were independently associated with frailty. Subgroup analyses revealed that corticosteroid use was associated with frailty deterioration in patients with baseline frailty (CFS ≥ 5), whereas SOFA scores were associated with frailty in patients with tissue hypoperfusion (lactate, ≥ 2 mmol/L).

CONCLUSIONS: Baseline frailty before sepsis, organ dysfunction severity, and corticosteroid therapy independently predict severe postintensive care frailty in older adults with septic shock.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Yamamoto R, Yamanaka T, Kaito D, et al. Postintensive Care Frailty of Older Patients With Septic Shock: A Post Hoc Analysis of a Multicenter Randomized Controlled Trial. Crit Care Med. 2026. PMID: 42584186. doi:10.1097/CCM.0000000000007304

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。